Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

NDI Notifications Take Center Stage In FDA's Evaluation Of DSHEA

Apr 10 2019

• By Malcolm Spicer

Vitamins

Related Content

DMAA, Other Stimulants Cast Shadow Over FDA Supplement Regulation – Study

Nov 14 2017

Supplement GMP Inspections Slowing As FDA Makes 'Potential' Data Useful

May 30 2018

FDA Could Stick With Current Advice On NDI Notifications, Old Ingredient Evidence

Jun 26 2018

DoJ Prosecutions: USPlabs Guilty, DMBA Firm Indicted From FDA Investigations

Mar 14 2019

Modernizing FDA's Supplement Industry Regulation Mapped Out In Five-Point Plan

Feb 12 2019

Additional Topics

International United States Dietary Supplements Regulation FDA Advertising, Marketing & Sales Commercial Companies Guidance Documents Ingredients Manufacturing Policy Safety Enforcement Consumer

More from Regulation

More from Policy & Regulation

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window